National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

everolimus (eh-veh-ROH-lih-mus)

 A drug used to treat advanced kidney cancer that did not respond to treatment with certain other anticancer drugs. It is also being studied in the treatment of other types of cancer. Everolimus stops cancer cells from dividing and may block the growth of new blood vessels that tumors need to grow. It also decreases the body’s immune responses. It is a type of immunosuppressant and a type of antiangiogenesis agent. Also called Afinitor and RAD001.



Previous Definitions:EUS-FNA, euthanasia, Evacet, evaluable disease, evaluable patients
Next Definitions:Evista, Ewing family of tumors, Ewing sarcoma, ex vivo, exatecan mesylate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov